Shopping Cart
- Remove All
Your shopping cart is currently empty
Ciprokiren is a renin inhibitor discovered by Roche. Ciprokinen inhibited human renin in a buffer and human plasma with an IC50 of 0.07 and 0.65 nmol/L, respectively. In animal models, acute and chronic administration of ciprokinen lead to a reduction in arterial blood pressure. Development of ciprokinen was discontinued at a preclinical stage.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $2,870 | 10-14 weeks | |
| 50 mg | $3,780 | 10-14 weeks | |
| 100 mg | $5,200 | 10-14 weeks |
| Description | Ciprokiren is a renin inhibitor discovered by Roche. Ciprokinen inhibited human renin in a buffer and human plasma with an IC50 of 0.07 and 0.65 nmol/L, respectively. In animal models, acute and chronic administration of ciprokinen lead to a reduction in arterial blood pressure. Development of ciprokinen was discontinued at a preclinical stage. |
| Molecular Weight | 729.93 |
| Formula | C37H55N5O8S |
| Cas No. | 143631-62-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.